PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
RPTTX
Price
$51.96
Change
+$0.55 (+1.07%)
Updated
Jul 25 closing price
Net Assets
3.82B
Interact to see
Advertisement

PMAQX vs RPTTX

Header iconPMAQX vs RPTTX Comparison
Open Charts PMAQX vs RPTTXBanner chart's image
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
T. Rowe Price Diversified Mid Cap Gr I
Price$51.96
Change+$0.55 (+1.07%)
VolumeN/A
Net Assets3.82B
PMAQX vs RPTTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. RPTTX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and RPTTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. RPTTX (3.82B). PMAQX pays higher dividends than RPTTX: PMAQX (0.19) vs RPTTX (0.00). PMAQX was incepted earlier than RPTTX: PMAQX (9 years) vs RPTTX (8 years). RPTTX (0.67) is less costly to investors than PMAQX (0.59). RPTTX is a more actively managed with annual turnover of: 46.80 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than RPTTX: PMAQX (0) vs RPTTX (500000). RPTTX annual gain was more profitable for investors over the last year : 19.81 vs. PMAQX (13.16). PMAQX return over 5 years is better than : 57.67 vs. RPTTX (31.75).
PMAQXRPTTXPMAQX / RPTTX
Total Expense Ratio0.590.6788%
Annual Report Gross Expense Ratio0.590.6788%
Fund Existence9 years8 years-
Gain YTD7.97711.95667%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets33B3.82B865%
Annual Yield % from dividends0.190.005,386%
Returns for 1 year13.1619.8166%
Returns for 3 years49.7645.58109%
Returns for 5 years57.6731.75182%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics